LOGITECH INTERNATIONAL S.A., 10-Q filed on 1/27/2022
Quarterly Report
v3.21.4
Cover Page - shares
9 Months Ended
Dec. 31, 2021
Jan. 12, 2022
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Dec. 31, 2021  
Document Transition Report false  
Entity File Number 0-29174  
Entity Registrant Name LOGITECH INTERNATIONAL S.A.  
Entity Incorporation, State or Country Code V8  
Entity Address, Address Line One 1015 Lausanne  
Entity Address, Country CH  
Entity Address, Address Line Two c/o Logitech Inc.  
Entity Address, Address Line Three 7700 Gateway Boulevard  
Entity Address, City or Town Newark  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94560  
City Area Code 510  
Local Phone Number 795-8500  
Title of 12(b) Security Registered Shares  
Trading Symbol LOGI  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   166,227,861
Entity Central Index Key 0001032975  
Amendment Flag false  
Current Fiscal Year End Date --03-31  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q3  
v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]        
Net sales $ 1,632,782 $ 1,667,302 $ 4,251,107 $ 3,716,354
Cost of goods sold 971,646 914,851 2,470,980 2,082,088
Amortization of intangible assets 3,126 3,441 11,028 9,800
Gross profit 658,010 749,010 1,769,099 1,624,466
Operating expenses:        
Marketing and selling 269,941 204,485 778,882 496,520
Research and development 75,529 53,910 213,436 157,014
General and administrative 38,478 37,606 112,291 98,341
Amortization of intangible assets and acquisition-related costs 3,662 4,946 13,986 13,886
Impairment of intangible assets 7,000 0 7,000 0
Change in fair value of contingent consideration for business acquisition (1,110) 0 (3,509) 5,716
Restructuring charges (credits), net 1,759 0 1,770 (54)
Total operating expenses 395,259 300,947 1,123,856 771,423
Operating income 262,751 448,063 645,243 853,043
Interest income 278 311 795 1,444
Other income (expense), net (3,673) 6,483 (1,941) 9,661
Income before income taxes 259,356 454,857 644,097 864,148
Provision for income taxes 49,345 72,334 107,789 142,638
Net income $ 210,011 $ 382,523 $ 536,308 $ 721,510
Net income per share:        
Basic (in dollars per share) $ 1.26 $ 2.26 $ 3.19 $ 4.28
Diluted (in dollars per share) $ 1.24 $ 2.22 $ 3.14 $ 4.21
Weighted average shares used to compute net income per share:        
Basic (in shares) 167,090 169,050 167,953 168,448
Diluted (in shares) 169,707 172,587 171,027 171,378
v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Statement of Comprehensive Income [Abstract]        
Net income $ 210,011 $ 382,523 $ 536,308 $ 721,510
Other comprehensive income (loss):        
Currency translation gain (loss), net of taxes (5,806) 19,500 (9,733) 23,944
Reclassification of cumulative translation adjustment to other income (expense), net 0 0 1,051 (1,738)
Defined benefit plans:        
Net gain (loss) and prior service costs, net of taxes (443) (863) (848) (319)
Amortization included in other income (expense), net 211 178 634 523
Hedging gain (loss):        
Deferred hedging gain (loss), net of taxes 1,061 (6,326) 3,723 (9,752)
Reclassification of net hedging impact into cost of goods sold (3,200) 3,446 (5,108) 5,085
Total other comprehensive income (loss) (8,177) 15,935 (10,281) 17,743
Total comprehensive income $ 201,834 $ 398,458 $ 526,027 $ 739,253
v3.21.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,364,411 $ 1,750,327
Accounts receivable, net 845,836 612,225
Inventories 834,534 661,116
Other current assets 145,001 135,650
Total current assets 3,189,782 3,159,318
Non-current assets:    
Property, plant and equipment, net 109,601 114,060
Goodwill 448,731 429,604
Other intangible assets, net 89,878 115,148
Other assets 323,605 324,248
Total assets 4,161,597 4,142,378
Current liabilities:    
Accounts payable 738,992 823,233
Accrued and other current liabilities 813,684 858,617
Total current liabilities 1,552,676 1,681,850
Non-current liabilities:    
Income taxes payable 85,610 59,237
Other non-current liabilities 155,369 139,502
Total liabilities 1,793,655 1,880,589
Commitments and contingencies
Shareholders’ equity:    
Registered shares, CHF 0.25 par value: Issued shares - 173,106 at December 31 and March 31, 2021 Additional shares that may be be issued out of conditional capitals - 50,000 at December 31 and March 31, 2021 Additional shares that may be issued out of authorized capitals - 17,311 at December 31 and March 31, 2021 30,148 30,148
Additional paid-in capital 115,994 129,519
Shares in treasury, at cost — 6,639 at December 31, 2021 and 4,799 at March 31, 2021 (526,480) (279,541)
Retained earnings 2,867,476 2,490,578
Accumulated other comprehensive loss (119,196) (108,915)
Total shareholders’ equity 2,367,942 2,261,789
Total liabilities and shareholders’ equity $ 4,161,597 $ 4,142,378
v3.21.4
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - SFr / shares
shares in Thousands
Dec. 31, 2021
Mar. 31, 2021
Shareholders’ equity:    
Shares, par value (in CHF per share) SFr 0.25 SFr 0.25
Shares issued (in shares) 173,106 173,106
Shares that may be issued out of conditional capital (in shares) 50,000 50,000
Shares that may be issued out of the authorized capital (in shares) 17,311 17,311
Treasury, at cost, shares (in shares) 6,639 4,799
v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:    
Net income $ 536,308 $ 721,510
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation 65,387 36,010
Amortization of intangible assets 24,223 23,627
Impairment of intangible assets 7,000 0
Loss on investments 1,421 4,692
Share-based compensation expense 72,465 64,714
Deferred income taxes 27,369 37,683
Change in fair value of contingent consideration for business acquisition (3,509) 5,716
Other 1,068 (1,670)
Changes in assets and liabilities, net of acquisitions:    
Accounts receivable, net (236,358) (476,804)
Inventories (177,828) (239,378)
Other assets (20,569) (53,281)
Accounts payable (80,637) 541,024
Accrued and other liabilities (17,612) 264,576
Net cash provided by operating activities 198,728 928,419
Cash flows from investing activities:    
Purchases of property, plant and equipment (63,726) (46,163)
Investment in privately held companies (1,260) (3,525)
Acquisitions, net of cash acquired (15,886) (360)
Proceeds from return of strategic investments 0 2,934
Purchases of short-term investments (10,000) 0
Proceeds from the sale of short-term investments 1,225 0
Purchases of trading investments (3,644) (10,672)
Proceeds from sales of trading investments 4,285 11,332
Net cash used in investing activities (89,006) (46,454)
Cash flows from financing activities:    
Payment of cash dividends (159,410) (146,705)
Payment of contingent consideration for business acquisition (880) 0
Purchases of registered shares (290,625) (72,725)
Proceeds from exercises of stock options and purchase rights 16,644 29,709
Tax withholdings related to net share settlements of restricted stock units (58,528) (29,475)
Net cash used in financing activities (492,799) (219,196)
Effect of exchange rate changes on cash and cash equivalents (2,839) 10,408
Net increase / (decrease) in cash and cash equivalents (385,916) 673,177
Cash and cash equivalents, beginning of the period 1,750,327 715,566
Cash and cash equivalents, end of the period 1,364,411 1,388,743
Non-cash investing and financing activities:    
Property, plant and equipment purchased during the period and included in period end liability accounts 13,707 14,663
Non-cash contingent consideration for acquisition 0 28,463
Fair value of contingent consideration in accrued and other liabilities 9,013 0
Supplemental cash flow information:    
Income taxes paid, net $ 175,775 $ 0
v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Registered Shares
Additional Paid-in Capital
Treasury Shares
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning of the period at Mar. 31, 2020 $ 1,489,268 $ (553) $ 30,148 $ 75,097 $ (185,896) $ 1,690,579 $ (553) $ (120,660)
Beginning of the period (in shares) at Mar. 31, 2020     173,106   6,210      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 739,253         721,510   17,743
Purchases of registered shares (72,725)       $ (72,725)      
Purchases of registered shares (in shares)         915      
Sales of shares upon exercise of stock options and purchase rights 29,709     (1,368) $ 31,077      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (1,461)      
Issuance of shares upon vesting of restricted stock units (29,475)     (48,968) $ 19,493      
Issuance of shares upon vesting of restricted stock units (in shares)         (1,031)      
Issuance of shares for contingent consideration 28,463     18,847 $ 9,616      
Issuance of shares for contingent consideration (in shares)         (390)      
Share-based compensation 64,532     64,532        
Cash dividends (146,705)         (146,705)    
End of the period at Dec. 31, 2020 2,101,767   $ 30,148 108,140 $ (198,435) 2,264,831   (102,917)
End of the period (in shares) at Dec. 31, 2020     173,106   4,243      
Beginning of the period at Sep. 30, 2020 1,705,963   $ 30,148 78,617 $ (166,258) 1,882,308   (118,852)
Beginning of the period (in shares) at Sep. 30, 2020     173,106   4,357      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 398,458         382,523   15,935
Purchases of registered shares (50,271)       $ (50,271)      
Purchases of registered shares (in shares)         603      
Sales of shares upon exercise of stock options and purchase rights 3,643     (2,733) $ 6,376      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (250)      
Issuance of shares upon vesting of restricted stock units (3,731)     (5,833) $ 2,102      
Issuance of shares upon vesting of restricted stock units (in shares)         (77)      
Issuance of shares for contingent consideration 28,463     18,847 $ 9,616      
Issuance of shares for contingent consideration (in shares)         (390)      
Share-based compensation 19,242     19,242        
End of the period at Dec. 31, 2020 2,101,767   $ 30,148 108,140 $ (198,435) 2,264,831   (102,917)
End of the period (in shares) at Dec. 31, 2020     173,106   4,243      
Beginning of the period at Mar. 31, 2021 2,261,789   $ 30,148 129,519 $ (279,541) 2,490,578   (108,915)
Beginning of the period (in shares) at Mar. 31, 2021     173,106   4,799      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 526,027         536,308   (10,281)
Purchases of registered shares (290,625)       $ (290,625)      
Purchases of registered shares (in shares)         3,035      
Sales of shares upon exercise of stock options and purchase rights 16,644     8,397 $ 8,247      
Sales of shares upon exercise of stock options and purchase rights (in shares)         (226)      
Issuance of shares upon vesting of restricted stock units (58,528)     (93,967) $ 35,439      
Issuance of shares upon vesting of restricted stock units (in shares)         (969)      
Share-based compensation 72,045     72,045        
Cash dividends (159,410)         (159,410)    
End of the period at Dec. 31, 2021 2,367,942   $ 30,148 115,994 $ (526,480) 2,867,476   (119,196)
End of the period (in shares) at Dec. 31, 2021     173,106   6,639      
Beginning of the period at Sep. 30, 2021 2,262,683   $ 30,148 99,434 $ (413,345) 2,657,465   (111,019)
Beginning of the period (in shares) at Sep. 30, 2021     173,106   5,331      
Increase (Decrease) in Shareholders' Equity                
Total comprehensive income 201,834         210,011   (8,177)
Purchases of registered shares (116,245)       $ (116,245)      
Purchases of registered shares (in shares)         1,379      
Sales of shares upon exercise of stock options and purchase rights 8     8        
Issuance of shares upon vesting of restricted stock units (3,777)     (6,887) $ 3,110      
Issuance of shares upon vesting of restricted stock units (in shares)         (71)      
Share-based compensation 23,439     23,439        
Cash dividends 0              
End of the period at Dec. 31, 2021 $ 2,367,942   $ 30,148 $ 115,994 $ (526,480) $ 2,867,476   $ (119,196)
End of the period (in shares) at Dec. 31, 2021     173,106   6,639      
v3.21.4
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Parenthetical)
3 Months Ended 9 Months Ended
Dec. 31, 2021
$ / shares
Dec. 31, 2021
$ / shares
Dec. 31, 2021
SFr / shares
Dec. 31, 2020
$ / shares
Dec. 31, 2020
SFr / shares
Statement of Stockholders' Equity [Abstract]          
Cash dividends per share (in dollars per share) | (per share) $ 0.95 $ 0.95 SFr 0.87 $ 0.87 SFr 0.79
v3.21.4
The Company and Summary of Significant Accounting Policies and Estimates
9 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
The Company and Summary of Significant Accounting Policies and Estimates The Company and Summary of Significant Accounting Policies and Estimates
The Company
 
Logitech International S.A, together with its consolidated subsidiaries ("Logitech" or the "Company"), designs, manufactures and markets products that have an everyday place in people's lives, connecting them to the digital experiences they care about. Forty years ago, Logitech created products to improve experiences around the personal PC platform, and today it is a multi-brand, multi-category company designing products that enable better experiences consuming, sharing and creating any digital content such as computing, gaming, video, and music, whether it is on a computer, mobile device or in the cloud.  
The Company sells its products to a broad network of domestic and international customers, including direct sales to retailers and e-tailers, and indirect sales through distributors.
Logitech was founded in Switzerland in 1981 and Logitech International S.A. has been the parent holding company of Logitech since 1988. Logitech International S.A. is a Swiss holding company with its registered office in Apples, Switzerland and headquarters in Lausanne, Switzerland, which conducts its business through subsidiaries in the Americas, Europe, Middle East and Africa ("EMEA") and Asia Pacific. Shares of Logitech International S.A. are listed on both the SIX Swiss Exchange under the trading symbol LOGN and the Nasdaq Global Select Market under the trading symbol LOGI.
Basis of Presentation
 
The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2021, included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 12, 2021. 

In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2022, or any future periods.

Changes in Significant Accounting Policies

Other than the recent accounting pronouncements adopted and discussed below under Recent Accounting Pronouncements Adopted, there have been no material changes in the Company’s significant accounting policies during the nine months ended December 31, 2021 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2021.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, contingent consideration for a business acquisition and periodic reassessment of its fair value, valuation of investment in privately held companies classified under Level 3 fair value hierarchy, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results could differ materially from those estimates.
 
Risks and Uncertainties
We are subject to risks and uncertainties as a result of the novel coronavirus ("COVID-19"). Capital markets and economies worldwide have been negatively impacted by COVID-19 and it is still unclear how lasting and deep the economic impacts will be. During the three and nine months ended December 31, 2021, the COVID-19 pandemic had mixed effects on the Company’s results of operations. While the Company experienced increased sales for the nine months ended December 31, 2021, compared to the same period of the prior fiscal year, we also experienced supply and demand volatility, as the COVID-19 pandemic and related safety measures and restrictions have evolved differently across the world. In addition, we experienced industry-wide supply chain challenges. The ongoing and full extent of the impact of the COVID-19 pandemic on the Company's business and operational and financial performance and condition, including the sustainability of its effect on trends positive to the Company, is uncertain and will depend on many factors outside the Company's control, including but not limited to the timing, extent, duration and effects of the virus and any of its mutations and variants, the vaccination rates, the development of effective treatments, the imposition of effective public safety and other protective measures and the public's response to such measures, the impact of COVID-19 on the global economy and demand for the Company's products and services. Should the COVID-19 pandemic or global economic slowdown not improve or worsen, or if the Company's attempt to mitigate its impact on its operations and costs is not successful, the Company's business, results of operations, financial condition and prospects may be adversely affected.
Recent Accounting Pronouncements Adopted
In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" (ASU 2019-12), which eliminates certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. This ASU also includes guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. ASU 2019-12 is effective for annual and interim periods in fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company adopted this standard effective April 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's condensed consolidated financial statements.

Recent Accounting Pronouncements to Be Adopted
In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers" (ASU 2021-08). The standard requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2021-08 to have a significant impact on its consolidated financial statements and plans to adopt the standard effective April 1, 2023.
v3.21.4
Net Income Per Share
9 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
 
The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2021 and December 31, 2020 (in thousands, except per share amounts):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Net income$210,011 $382,523 $536,308 $721,510 
Shares used in net income per share computation:    
Weighted average shares outstanding - basic167,090 169,050 167,953 168,448 
Effect of potentially dilutive equivalent shares2,617 3,537 3,074 2,930 
Weighted average shares outstanding - diluted169,707 172,587 171,027 171,378 
Net income per share:    
Basic$1.26 $2.26 $3.19 $4.28 
Diluted$1.24 $2.22 $3.14 $4.21 
 
Share equivalents attributable to outstanding stock options, restricted stock units ("RSUs") and employee share purchase plans ("ESPP") totaling 0.8 million and 0.3 million for the three months ended December 31, 2021 and 2020, respectively, and 0.9 million and 0.4 million for the nine months ended December 31, 2021 and 2020, respectively, were excluded from the calculation of diluted net income per share because the combined exercise price and average unamortized grant date fair value upon exercise of these options and ESPP rights or vesting of RSUs were greater than the average market price of the Company's shares during the periods presented herein, and therefore their inclusion would have been anti-dilutive. A small number of performance-based awards were not included in the calculation because all necessary conditions had not been satisfied by the end of the respective period, and those shares were not issuable if the end of the reporting period were the end of the performance contingency period.
v3.21.4
Employee Benefit Plans
9 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Employee Benefit Plans Employee Benefit Plans
 
Employee Share Purchase Plans and Stock Incentive Plans
 
As of December 31, 2021, the Company offers the 2006 Employee Share Purchase Plan (Non-U.S.), as amended and restated, the 1996 Employee Share Purchase Plan (U.S.), as amended and restated, the 2006 Stock Incentive Plan, as amended and restated, and the 2012 Stock Inducement Equity Plan. Shares issued to employees as a result of purchases or exercises under these plans are generally issued from shares held in treasury stock.

The following table summarizes the share-based compensation expense and total income tax benefit recognized for share-based awards for the three and nine months ended December 31, 2021 and 2020 (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Cost of goods sold$1,782 $1,747 $5,253 $4,919 
Marketing and selling10,699 8,390 28,987 27,559 
Research and development4,510 3,482 14,295 10,348 
General and administrative7,801 6,195 23,930 21,888 
Total share-based compensation expense24,792 19,814 72,465 64,714 
Income tax benefit(3,581)(3,471)(23,460)(15,540)
Total share-based compensation expense, net of income tax benefit$21,211 $16,343 $49,005 $49,174 

The income tax benefit in the respective periods primarily consisted of tax benefits related to the share-based compensation expense for the period and direct tax benefit realized, including net excess tax benefits recognized from share-based awards vested or exercised during the period.

As of December 31, 2021 and 2020, the balance of capitalized share-based compensation included in inventory was $1.1 million and $1.0 million, respectively.
 
Defined Benefit Plans
 
Certain of the Company’s subsidiaries sponsor defined benefit pension plans or non-retirement post-employment benefits covering substantially all of their employees. Benefits are provided based on employees’ years of service and earnings, or in accordance with applicable employee benefit regulations. The Company’s practice is to fund amounts sufficient to meet the requirements set forth in the applicable employee benefit and tax regulations. The costs recorded of $3.4 million and $2.9 million for the three months ended December 31, 2021 and 2020, respectively, and $10.0 million and $8.3 million for the nine months ended December 31, 2021 and 2020, respectively, were primarily related to service costs.
v3.21.4
Income Taxes
9 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
 
The Company is incorporated in Switzerland but operates in various countries with differing tax laws and rates. Further, a portion of the Company’s income before taxes and the provision for (benefit from) income taxes are generated outside of Switzerland.

The income tax provision for the three months ended December 31, 2021 was $49.3 million based on an effective income tax rate of 19.0% of pre-tax income, compared to an income tax provision of $72.3 million based on an effective income tax rate of 15.9% of pre-tax income for the three months ended December 31, 2020. The income tax provision for the nine months ended December 31, 2021 was $107.8 million based on an effective income tax rate of 16.7% of pre-tax income, compared to an income tax provision of $142.6 million based on an effective income tax rate of 16.5% of pre-tax income for the nine months ended December 31, 2020.

The change in the effective income tax rate for the three and nine months ended December 31, 2021, compared to the same periods ended December 31, 2020 was primarily due to the mix of income and losses in the
various tax jurisdictions in which the Company operates. There were discrete tax benefits of $0.8 million and $1.3 million from the recognition of excess tax benefits in the United States and reversal of uncertain tax positions from the expiration of statutes of limitations, respectively, in the three-month period ended December 31, 2021, compared with $1.3 million and $1.4 million, respectively, in the three-month period ended December 31, 2020. There were discrete tax benefits of $15.2 million and $2.8 million from the recognition of excess tax benefits in the United States and the reversal of uncertain tax positions from the expiration of statutes of limitations, respectively, in the nine-month period ended December 31, 2021, compared with $7.2 million and $2.9 million, respectively, in the nine-month period ended December 31, 2020.

As of December 31, 2021 and March 31, 2021, the total amount of unrecognized tax benefits due to uncertain tax positions was $178.6 million and $160.3 million, respectively, all of which would affect the effective income tax rate if recognized.

As of December 31, 2021 and March 31, 2021, the Company had $85.6 million and $59.2 million, respectively, in non-current income taxes payable including interest and penalties, related to the Company's income tax liability for uncertain tax positions.
 
The Company recognizes interest and penalties related to unrecognized tax positions in the income tax provision. As of December 31, 2021 and March 31, 2021, the Company had $5.7 million and $4.9 million, respectively, of accrued interest and penalties related to uncertain tax positions in non-current income taxes payable.
 
Although the Company has adequately provided for uncertain tax positions, the provisions related to these positions may change as revised estimates are made or the underlying matters are settled or otherwise resolved. During fiscal year 2022, the Company continues to review its tax positions and provide for or reverse unrecognized tax benefits as they arise. During the next twelve months, it is reasonably possible that the amount of unrecognized tax benefits could increase or decrease significantly due to changes in tax law in various jurisdictions, new tax audits and changes in the U.S. dollar as compared to other currencies. Excluding these factors, uncertain tax positions may decrease by as much as $5.2 million from the lapse of the statutes of limitations in various jurisdictions during the next twelve months.
v3.21.4
Balance Sheet Components
9 Months Ended
Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components Balance Sheet Components
 
The following table presents the components of certain balance sheet asset amounts as of December 31 and March 31, 2021 (in thousands): 
December 31, 2021March 31, 2021
Accounts receivable, net:  
Accounts receivable$1,189,206 $867,868 
Allowance for doubtful accounts(75)(1,161)
Allowance for sales returns(15,128)(14,438)
Allowance for cooperative marketing arrangements(66,772)(43,276)
Allowance for customer incentive programs(125,052)(76,200)
Allowance for pricing programs(136,343)(120,568)
 $845,836 $612,225 
Inventories:  
Raw materials$209,647 $146,886 
Finished goods624,887 514,230 
 $834,534 $661,116 
Other current assets:  
Value-added tax receivables$56,944 $67,710 
Prepaid expenses and other assets88,057 67,940 
 $145,001 $135,650 
Property, plant and equipment, net:  
Property, plant and equipment at cost$451,783 $417,520 
Accumulated depreciation and amortization(342,182)(303,460)
$109,601 $114,060 
Other assets:  
Deferred tax assets$196,776 $210,888 
Right-of-use assets 38,997 31,169 
Trading investments for deferred compensation plan29,711 24,809 
Investments in privately held companies43,482 43,402 
Other assets14,639 13,980 
 $323,605 $324,248 
The following table presents the components of certain balance sheet liability amounts as of December 31 and March 31, 2021 (in thousands): 
December 31, 2021March 31, 2021
Accrued and other current liabilities:  
Accrued customer marketing, pricing and incentive programs$244,821 $185,394 
Accrued personnel expenses167,249 173,360 
VAT payable41,103 50,620 
Accrued sales return liability37,765 43,178 
Accrued payables - non-inventory29,632 52,392 
Warranty accrual34,121 33,228 
Income taxes payable25,889 131,408 
Operating lease liability13,583 13,101 
Contingent consideration8,580 6,967 
Other current liabilities210,941 168,969 
 $813,684 $858,617 
Other non-current liabilities:  
Employee benefit plan obligations$74,643 $72,321 
Obligation for deferred compensation plan29,711 24,809 
Operating lease liability27,464 21,319 
Warranty accrual13,814 15,604 
Contingent consideration3,971 — 
Deferred tax liability1,679 1,679 
Other non-current liabilities4,087 3,770 
 $155,369 $139,502 
v3.21.4
Fair Value Measurements
9 Months Ended
Dec. 31, 2021
Financial Instruments, Owned, at Fair Value [Abstract]  
Fair Value Measurements Fair Value Measurements
 
Fair Value Measurements
 
The Company considers fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. The Company utilizes the following three-level fair value hierarchy to establish the priorities of the inputs used to measure fair value:
 
Level 1 — Quoted prices in active markets for identical assets or liabilities.
 
Level 2 — Observable inputs other than quoted market prices included in Level 1, such as: quoted prices for similar assets and liabilities in active markets; quoted prices for identical or similar assets and liabilities in markets that are not active; or other inputs that are observable or can be corroborated by observable market data.
 
Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): 
 December 31, 2021March 31, 2021
 Level 1Level 2Level 3Level 1Level 2Level 3
Assets:    
Cash equivalents$475,187 $— $— $669,759 $— $— 
       
Trading investments for deferred compensation plan included in other assets:    
Cash$349 $— $— $31 $— $— 
Common stock2,240 — — 1,569 — — 
Money market funds7,117 — — 6,734 — — 
Mutual funds20,005 — — 16,475 — — 
Total of trading investments for deferred compensation plan$29,711 $— $— $24,809 $— $— 
Currency exchange derivative assets
included in other current assets
$— $198 $— $— $5,452 $— 
Liabilities:
Contingent consideration for business acquisition included in accrued and other current liabilities$— $— $8,042 $— $— $6,430 
Contingent consideration for business acquisition included in other non-current liabilities$— $— $3,971 $— $— $— 
Currency exchange derivative liabilities
included in accrued and other current liabilities
$— $808 $— $— $100 $— 
The following table summarizes the change in the fair value of the Company's contingent consideration balance during the nine months ended December 31, 2021 and 2020 (in thousands):
Nine Months Ended
December 31,
20212020
Beginning of the period$6,967 $23,284 
Fair value of contingent consideration upon acquisition (1)
9,973 — 
Change in fair value of contingent consideration(3,509)5,716 
Settlement of contingent consideration(880)(28,463)
End of the period (2)
$12,551 $537 
(1) Fair value of contingent consideration includes the earn-out of the immaterial technology acquisition. See Contingent Consideration for Business Acquisitions section below for more information.

(2) As of June 30, 2020, the earn-out period was completed in connection with our acquisition of General Workings, Inc. ("Streamlabs") (discussed below). The earn-out payment of $29.0 million was based on the actual net sales of Streamlabs services during the earn-out period and was no longer subject to fair value measurement and was accordingly transferred out of Level 3. During the third quarter of fiscal year 2021, $28.5 million of the contingent consideration was transferred from other current liabilities to equity upon settlement of the contingent consideration through the issuance of shares out of treasury stock. The remaining $0.5 million is held back in escrow for claims made against the escrow and for the payment of taxes.

Investment Securities
 
The marketable securities for the Company's deferred compensation plan were recorded at a fair value of $29.7 million and $24.8 million, as of December 31, 2021 and March 31, 2021, respectively, based on quoted
market prices. Quoted market prices are observable inputs that are classified as Level 1 within the fair value hierarchy. Unrealized gains (losses) related to trading securities for the three and nine months ended December 31, 2021 and 2020 were not material and are included in other income, net in the Company's condensed consolidated statements of operations.

Contingent Consideration for Business Acquisitions

On May 19, 2021, the Company made an immaterial technology acquisition. The contingent consideration for business acquisition arising from the immaterial technology acquisition represents the future potential earn-out payments of up to $10.0 million payable in cash only upon the achievement of three technical development milestones required to be completed as of December 31, 2021, June 30, 2022, and June 30, 2023. The fair value of the contingent amount was determined using a probability-weighted expected payment model and discounted at the estimated cost of debt. During the third quarter of fiscal 2022, $0.9 million of the contingent consideration was released from other current liabilities upon cash settlement of the contingent consideration for the first technical development milestone.

On February 17, 2021 (the "Mevo Acquisition Date"), the Company acquired all of the equity interests of Mevo Inc. ("Mevo"). In connection with the acquisition of Mevo, the Company agreed to pay a total earn out payment of up to $17.0 million payable in cash only upon the achievement of certain net sales for the period beginning on December 26, 2020 and ending on December 31, 2021.

The fair value of the earn-out as of the Mevo Acquisition Date was $3.4 million which was determined by using a Black-Scholes-Merton valuation model to calculate the probability of the earn-out threshold being met, times the value of the earn-out payment, and discounted at the risk-free rate. The valuation included significant assumptions and unobservable inputs such as the projected sales of Mevo over the earn-out period, risk-free rate, and the net sales volatility. Projected sales were based on the Company's internal projections, including analysis of the target market and historical sales of Mevo products. As of December 31, 2021, the fair value of the contingent consideration was released from other current liabilities as the net sales milestone was not achieved upon completion of the earn-out period. As of March 31, 2021 the fair value of the contingent consideration was $3.4 million.

On January 4, 2021, the Company made an immaterial technology acquisition. The contingent consideration for business acquisition arising from the immaterial technology acquisition represents the future potential earn-out payments of up to $3.0 million payable in cash upon the achievement of two technical development milestones required to be completed as of December 31, 2021 and March 31, 2022. The fair value of the contingent amount was determined using a probability-weighted expected payment model and discounted at the estimated cost of debt. The contingent consideration related to the first milestone is expected to be paid in the fourth quarter of fiscal year 2022.

On October 31, 2019, the Company acquired all of the equity interests of General Workings, Inc. (Streamlabs). In connection with the acquisition of Streamlabs, the Company agreed to pay a total earn-out payment of up to $29.0 million, payable in stock, only upon the achievement of certain net revenues for the period beginning on January 1, 2020 and ending on June 30, 2020. The fair value was increased by $5.7 million to $29.0 million as of June 30, 2020, based on actual sales. As of June 30, 2020, the earn-out period was completed, and was no longer subject to fair value measurement. During the third quarter of fiscal 2021, $28.5 million of the contingent consideration was transferred from other current liabilities to equity upon settlement of the contingent consideration through the issuance of shares out of treasury stock. The remaining amount of $0.5 million is held back in escrow for claims made against the escrow and for the payment of taxes.

Although these estimates are based on management’s best knowledge of current events, the estimates could change significantly from period to period. Actual results that differ from the assumptions used and any changes to the significant assumptions and unobservable inputs used could have a material impact on future results of operations.

Equity Method Investments

The Company has certain non-marketable investments included in other assets that are accounted for under the equity method of accounting, with a carrying value of $40.8 million and $40.7 million as of December 31, 2021 and March 31, 2021, respectively. Unrealized gains (losses) related to equity investments for the three and nine months ended December 31, 2021 and 2020 were not material and are included in other income, net in the
Company's condensed consolidated statements of operations. There was no impairment of these assets during the three and nine months ended December 31, 2021 or 2020.

Other Assets Measured at Fair Value on a Nonrecurring Basis

Financial Assets.  The Company has certain investments without readily determinable fair values due to the absence of quoted market prices, the inherent lack of liquidity, and the fact that inputs used to measure fair value are unobservable and require management's judgment. When certain events or circumstances indicate that impairment may exist, the Company revalues the investments using various assumptions, including the financial metrics and ratios of comparable public companies. The carrying value is also adjusted for observable price changes with a same or similar security from the same issuer. The amount of these investments included in other assets was immaterial as of December 31, 2021 and March 31, 2021. There was no impairment of these assets during the three and nine months ended December 31, 2021 or 2020.

Non-Financial Assets. Goodwill, intangible assets, and property, plant and equipment, are not required to be measured at fair value on a recurring basis. However, if certain triggering events occur (or tested at least annually for goodwill) such that a non-financial instrument is required to be evaluated for impairment and an impairment is recorded to reduce the non-financial instrument's carrying value to the fair value as a result of such triggering events, the non-financial assets and liabilities are measured at fair value for the period such triggering events occur. As further discussed in Note 8, during the three and nine months ended December 31, 2021, the Company recorded impairment charges of $7.0 million for the Jaybird intangible assets. There was no impairment of non-financial assets during the three and nine months ended December 31, 2020.
v3.21.4
Derivative Financial Instruments
9 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments Derivative Financial Instruments
 
Under certain agreements with the respective counterparties to the Company’s derivative contracts, subject to applicable requirements, the Company is allowed to net settle transactions of the same type with a single net amount payable by one party to the other. However, the Company presents its derivative assets and derivative liabilities on a gross basis on the condensed consolidated balance sheets as of December 31, 2021 and March 31, 2021.

The fair value of the Company’s derivative instruments was not material as of December 31, 2021 or March 31, 2021. The amount of gain (loss) recognized on derivatives not designated as hedging instruments was not material in all periods presented herein. The following table presents the amounts of gains (losses) on the Company’s derivative instruments designated as hedging instruments and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income for the three and nine months ended December 31, 2021 and 2020 (in thousands):
Three Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss
Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
 2021202020212020
Cash flow hedges$1,061 $(6,326)$(3,200)$3,446 
Nine Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss
Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
2021202020212020
Cash flow hedges$3,723 $(9,752)$(5,108)$5,085 
Cash Flow Hedges
 
The Company enters into cash flow hedge contracts to protect against exchange rate exposure of forecasted inventory purchases. These hedging contracts mature within four months. Gains and losses in the fair value of the effective portion of the hedges are deferred as a component of accumulated other comprehensive loss until the hedged inventory purchases are sold, at which time the gains or losses are reclassified to cost of goods sold. Cash flows from such hedges are classified as operating activities in the condensed consolidated statements of cash flows. Hedging relationships are discontinued when hedging contract is no longer eligible for hedge accounting, or is sold, terminated or exercised, or when Company removes hedge designation for the contract. Gains and losses in the fair value of the effective portion of the discontinued hedges continue to be reported in accumulated other comprehensive loss until the hedged inventory purchases are sold, unless it is probable that the forecasted inventory purchases will not occur by the end of the originally specified time period or within an additional two-month period of time thereafter. In all periods presented herein, there have been no forecasted inventory purchases that were probable to not occur by the end of the originally specified time period or within an additional two-month period of time thereafter. The notional amounts of foreign currency exchange forward contracts outstanding related to forecasted inventory purchases were $128.1 million as of December 31, 2021 and $164.5 million as of March 31, 2021. The Company had $2.4 million of net gains related to its cash flow hedges included in accumulated other comprehensive loss as of December 31, 2021, which will be reclassified into earnings within the next 12 months.
 
Other Derivatives
 
The Company also enters into foreign currency exchange forward and swap contracts to reduce the short-term effects of currency exchange rate fluctuations on certain receivables or payables denominated in currencies other than the functional currencies of its subsidiaries. These contracts generally mature within one month. The primary risk managed by using forward and swap contracts is the currency exchange rate risk. The gains or losses on these contracts are recognized in other income, net in the condensed consolidated statements of operations based on the changes in fair value. The notional amounts of these contracts outstanding as of December 31, 2021 and March 31, 2021 were $251.7 million and $123.8 million, respectively. Open forward and swap contracts outstanding as of December 31, 2021 and March 31, 2021 consisted of contracts in Mexican Pesos, Japanese Yen, Canadian Dollars, Taiwanese Dollars, and Australian Dollars to be settled at future dates at pre-determined exchange rates. Open forward and swap contracts outstanding as of December 31, 2021 additionally consisted of contracts in Chinese Renminbi and Brazilian Real to be settled at future dates at pre-determined exchange rates, which were primarily attributable to the increase in the notional amounts outstanding as of December 31, 2021 compared to March 31, 2021.
 
The fair value of all foreign currency exchange forward and swap contracts is determined based on observable market transactions of spot currency rates and forward rates. Cash flows from these contracts are classified as operating activities in the condensed consolidated statements of cash flows.
v3.21.4
Goodwill and Other Intangible Assets
9 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Other Intangible Assets Goodwill and Other Intangible Assets
The Company conducts its impairment analysis of goodwill and indefinite life intangible assets annually at December 31 and as necessary, if changes in facts and circumstances indicate that it is more likely than not that the fair value of the Company’s reporting unit may be less than its carrying amount. The Company conducted its annual impairment analysis of goodwill and indefinite life intangible asset as of December 31, 2021 by performing a qualitative assessment and concluded that it was more likely than not that the fair value of its reporting unit exceeds its carrying amount. In assessing the qualitative factors, the Company considered the impact of change in industry and competitive environment, growth in the Company's market capitalization and budgeted-to-actual revenue performance for the last twelve months.

The following table summarizes the activities in the Company’s goodwill balance during the nine months ended December 31, 2021 (in thousands):

As of March 31, 2021$429,604 
Acquisition20,721 
Effects of foreign currency translation(1,594)
As of December 31, 2021$448,731 
During the third quarter of fiscal 2022, the Company decided to discontinue Jaybird-branded products. As a result of this decision, the Company performed an analysis to compare the fair value of Jaybird-related intangible assets to their carrying amount. As the fair value using estimated discounted cash flows was less than the carrying amount, the Company recognized a pre-tax impairment charge in the condensed consolidated statement of operations of $7.0 million, which was primarily related to customer contracts and relationships. See Note 13 for further information regarding the exit plan.
On May 19, 2021, the Company made an immaterial technology acquisition for a total cash consideration of $25.6 million, including up to $10.0 million earn-out payable in cash upon the achievement of three technical development milestones required to be completed as of December 31, 2021, June 30, 2022, and June 30, 2023, which was accounted for using the acquisition method. The Company retained 6% of the total consideration for the purpose of ensuring seller's representations and warranties.

The Company's acquired intangible assets subject to amortization were as follows (in thousands):
 December 31, 2021March 31, 2021
 Gross Carrying AmountAccumulated
Amortization
Net Carrying AmountGross Carrying AmountAccumulated
Amortization
Net Carrying Amount
Trademark and trade names$36,790 $(21,112)$15,678 $46,070 $(25,153)$20,917 
Developed technology119,707 (80,545)39,162 134,406 (90,450)43,956 
Customer contracts/relationships71,110 (39,172)31,938 91,010 (44,261)46,749 
In-process R&D3,526 — 3,526 3,526 — 3,526 
Effects of foreign currency translation(475)49 (426)— — — 
Total$230,658 $(140,780)$89,878 $275,012 $(159,864)$115,148 
v3.21.4
Financing Arrangements
9 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
Financing Arrangements Financing Arrangements
 
The Company had several uncommitted, unsecured bank lines of credit aggregating $194.4 million as of December 31, 2021. There are no financial covenants under these lines of credit with which the Company must comply. As of December 31, 2021, the Company had outstanding bank guarantees of $11.8 million under these lines of credit. There was no borrowing outstanding under these lines of credit as of December 31, 2021 or March 31, 2021.
v3.21.4
Commitments and Contingencies
9 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
 
Product Warranties
 
Changes in the Company’s warranty liability for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands): 
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Beginning of the period$49,173 $41,782 $48,832 $40,039 
Provision6,962 13,692 23,503 28,575 
Settlements(8,056)(8,371)(24,219)(22,073)
Effects of foreign currency translation(144)489 (181)1,051 
End of the period$47,935 $47,592 $47,935 $47,592 

Indemnifications
 
The Company indemnifies certain of its suppliers and customers for losses arising from matters such as intellectual property disputes and product safety defects, subject to certain restrictions. The scope of these indemnities varies, but in some instances, includes indemnification for damages and expenses, including
reasonable attorneys’ fees. As of December 31, 2021, no amounts have been accrued for these indemnification provisions. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under its indemnification arrangements.
 
The Company also indemnifies its current and former directors and certain of its current and former officers. Certain costs incurred for providing such indemnification may be recoverable under various insurance policies. The Company is unable to reasonably estimate the maximum amount that could be payable under these arrangements because these exposures are not limited, the obligations are conditional in nature and the facts and circumstances involved in any situation that might arise are variable.

Legal Proceedings
From time to time the Company is involved in claims and legal proceedings which arise in the ordinary course of its business. The Company is currently subject to several such claims and a small number of legal proceedings. The Company believes that these matters lack merit and intends to vigorously defend against them. Based on currently available information, the Company does not believe that resolution of pending matters will have a material adverse effect on its financial position, cash flows or results of operations. However, litigation is subject to inherent uncertainties, and there can be no assurances that the Company's defenses will be successful or that any such lawsuit or claim would not have a material adverse impact on the Company's business, financial position, cash flows or results of operations in a particular period. Any claims or proceedings against the Company, whether meritorious or not, can have an adverse impact because of defense costs, diversion of management and operational resources, negative publicity and other factors. Any failure to obtain a necessary license or other rights, or litigation arising out of intellectual property claims, could adversely affect the Company's business.
v3.21.4
Shareholders' Equity
9 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Shareholders' Equity Shareholders’ Equity
Share Repurchase Program

In March 2017, the Company's Board of Directors approved the 2017 share repurchase program, which authorized the Company to use up to $250.0 million to purchase up to 17.3 million shares of Logitech shares. This share repurchase program expired in April 2020.

In May 2020, the Company's Board of Directors approved the 2020 share repurchase program, which authorized the Company to use up to $250.0 million to purchase up to 17.3 million of Logitech shares. The Company's share repurchase program is expected to remain in effect for a period of three years. Shares may be repurchased from time to time on the open market, through block trades or otherwise. Purchases may be started or stopped at any time without prior notice depending on market conditions and other factors. In April 2021, the Company's Board of Directors approved an increase of $750.0 million of the 2020 share repurchase program, to an aggregate amount of $1.0 billion. The Swiss Takeover Board approved this increase and it became effective on May 21, 2021. As of December 31, 2021, $545.0 million is still available for repurchase under the 2020 repurchase program.

Dividends
During the nine months ended December 31, 2021, the Company declared and paid cash dividends of CHF 0.87 (USD equivalent of $0.95) per share, totaling $159.4 million on the Company's outstanding shares. During the nine months ended December 31, 2020, the Company declared and paid cash dividends of CHF 0.79 (USD equivalent of $0.87) per share, totaling $146.7 million on the Company's outstanding shares.
Any future dividends will be subject to approval of the Company's shareholders.
Accumulated Other Comprehensive Income (Loss)
 
The accumulated other comprehensive income (loss) was as follows (in thousands):
 Accumulated Other Comprehensive Income (Loss)
Cumulative
Translation
Adjustment
Defined
Benefit
Plan
Deferred Hedging Gains / (Losses)Total
March 31, 2021$(89,461)$(23,200)$3,746 $(108,915)
Other comprehensive gains (losses)(8,682)(214)(1,385)(10,281)
December 31, 2021$(98,143)$(23,414)$2,361 $(119,196)
v3.21.4
Segment Information
9 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Segment Information Segment Information
 
The Company operates in a single operating segment that encompasses the design, manufacturing and marketing of peripherals for PCs, tablets and other digital platforms. Operating performance measures are provided directly to the Company's CEO, who is considered to be the Company’s Chief Operating Decision Maker. The CEO periodically reviews information such as sales and adjusted operating income (loss) to make business decisions. These operating performance measures do not include restructuring charges (credits), net, share-based compensation expense, amortization of intangible assets, charges from the purchase accounting effect on inventory, acquisition-related costs, or change in fair value of contingent consideration from business acquisition.

Sales by product categories and sales channels, excluding intercompany transactions, for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Pointing Devices$231,090 $213,638 $602,982 $503,228 
Keyboards & Combos281,608 218,269 736,237 565,246 
PC Webcams115,115 131,700 319,504 295,020 
Tablet & Other Accessories82,859 138,052 242,932 267,186 
Gaming (1)
469,282 436,426 1,135,456 916,040 
Video Collaboration287,187 292,500 753,725 659,278 
Mobile Speakers56,748 72,566 124,724 145,156 
Audio & Wearables104,280 152,952 318,965 338,592 
Smart Home4,559 10,593 16,380 25,976 
Other (2)
54 606 202 632 
Total Sales$1,632,782 $1,667,302 $4,251,107 $3,716,354 

(1) Gaming includes streaming services revenue generated by Streamlabs.
(2) Other includes products that the Company currently intends to phase out, or has already phased out, because they are no longer strategic to the Company's business.
Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
2021202020212020
Americas$674,393 $704,718 $1,828,474 $1,603,221 
EMEA552,133 547,044 1,309,542 1,147,393 
Asia Pacific406,256 415,540 1,113,091 965,740 
Total sales$1,632,782 $1,667,302 $4,251,107 $3,716,354 
 
Sales are attributed to countries on the basis of the customers’ locations.

The United States and Germany each represented 10% or more of the total consolidated sales for each of the periods presented herein. China represented more than 10% of the total consolidated sales for the three and nine months ended December 31, 2021. No other countries represented 10% or more of the Company’s total consolidated sales for the periods presented herein.

Switzerland, the Company’s home domicile, represented 3% of the Company's total consolidated sales for each of the periods presented herein.

Two customers of the Company each represented 10% or more of the total consolidated sales for each of the periods presented herein.
Property, plant and equipment, net by geographic region were as follows (in thousands):
December 31, 2021March 31, 2021
Americas$18,071 $20,810 
EMEA15,245 8,019 
Asia Pacific76,285 85,231 
Total property, plant and equipment, net$109,601 $114,060 
 
Property, plant and equipment, net in the United States and China were $17.8 million, $64.1 million, respectively, as of December 31, 2021, and $20.5 million and $74.0 million, respectively, as of March 31, 2021. Property, plant and equipment, net in Switzerland, the Company’s home domicile, were $12.7 million and $5.7 million as of December 31, 2021 and March 31, 2021, respectively. Switzerland represented more than 10% of the Company's total consolidated property, plant and equipment, net as of December 31, 2021. No other countries represented 10% or more of the Company’s total consolidated property, plant and equipment, net as of December 31, 2021 or March 31, 2021.
v3.21.4
Restructuring
9 Months Ended
Dec. 31, 2021
Restructuring and Related Activities [Abstract]  
Restructuring Restructuring
During the third quarter of fiscal 2022, as part of the Company's strategic review, the Company decided to cease future product launches under the Jaybird brand within the Audio & Wearables product category. As a result, the Company recorded pre-tax restructuring charges of $1.8 million for the three and nine months ended December 31, 2021, which are included in the condensed consolidated statement of operations as restructuring charges (credits), net. The accrual balances are presented in accrued and other current liabilities in the condensed consolidated balance sheets.

Total charges related to the exit of Jaybird-branded products were $16.3 million, which included restructuring charges and other costs, for the three and nine months ended December 31, 2021. The restructuring charges consisted of $1.3 million, primarily related to costs of production cancellation and $0.5 million related to cash severance and termination benefits. The Company also recorded $7.6 million in cost of goods sold related to write-offs for excess inventories. In addition, as discussed in Note 8, the Company recognized a pre-tax impairment charge of $7.0 million, related to intangible assets acquired as part of the Jaybird acquisition. The Company expects to substantially complete this restructuring within the next twelve months.

The following table presents a rollforward of the restructuring liability for the nine months ended December 31, 2021 (in thousands):
 Termination
Benefits
OtherTotal
Accrual balance at March 31, 2021$— $— $— 
Charges472 1,287 1,759 
Cash payments— — — 
Accrual balance at December 31, 2021$472 $1,287 $1,759 
v3.21.4
The Company and Summary of Significant Accounting Policies and Estimates (Policies)
9 Months Ended
Dec. 31, 2021
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
 
The condensed consolidated financial statements include the accounts of Logitech and its subsidiaries. All intercompany balances and transactions have been eliminated. The condensed consolidated financial statements are presented in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and therefore do not include all the information required by U.S. GAAP for complete financial statements. The condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the fiscal year ended March 31, 2021, included in its Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 12, 2021. 

In the opinion of management, these condensed consolidated financial statements include all adjustments, consisting of only normal and recurring adjustments, necessary and in all material aspects, for a fair statement of the results of operations, comprehensive income, financial position, cash flows and changes in shareholders' equity for the periods presented. Operating results for the three and nine months ended December 31, 2021 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2022, or any future periods.
Changes in Significant Accounting Policies and Recent Accounting Pronouncements Adopted and Recent Accounting Pronouncements to Be Adopted
Changes in Significant Accounting Policies

Other than the recent accounting pronouncements adopted and discussed below under Recent Accounting Pronouncements Adopted, there have been no material changes in the Company’s significant accounting policies during the nine months ended December 31, 2021 compared with the significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended March 31, 2021.
Recent Accounting Pronouncements Adopted
In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes" (ASU 2019-12), which eliminates certain exceptions for recognizing deferred taxes for investments, performing intraperiod allocation and calculating income taxes in interim periods. This ASU also includes guidance to reduce complexity in certain areas, including recognizing deferred taxes for tax goodwill and allocating taxes to members of a consolidated group. ASU 2019-12 is effective for annual and interim periods in fiscal years beginning after December 15, 2020. Early adoption is permitted. The Company adopted this standard effective April 1, 2021. The adoption of ASU 2019-12 did not have a material impact on the Company's condensed consolidated financial statements.

Recent Accounting Pronouncements to Be Adopted
In October 2021, the FASB issued ASU 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers" (ASU 2021-08). The standard requires an acquirer in a business combination to recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. The standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted. The Company does not expect the adoption of ASU 2021-08 to have a significant impact on its consolidated financial statements and plans to adopt the standard effective April 1, 2023.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements. Management bases its estimates on historical experience and various other assumptions believed to be reasonable. Significant estimates and assumptions made by management involve the fair value of goodwill and intangible assets acquired from business acquisitions, contingent consideration for a business acquisition and periodic reassessment of its fair value, valuation of investment in privately held companies classified under Level 3 fair value hierarchy, pension obligations, accruals for customer incentives, cooperative marketing, and pricing programs and related breakage when appropriate, inventory valuation, share-based compensation expense, uncertain tax positions, and valuation allowances for deferred tax assets. Although these estimates are based on management’s best knowledge of current events and actions that may impact the Company in the future, actual results could differ materially from those estimates.
Risks and Uncertainties
Risks and Uncertainties
We are subject to risks and uncertainties as a result of the novel coronavirus ("COVID-19"). Capital markets and economies worldwide have been negatively impacted by COVID-19 and it is still unclear how lasting and deep the economic impacts will be. During the three and nine months ended December 31, 2021, the COVID-19 pandemic had mixed effects on the Company’s results of operations. While the Company experienced increased sales for the nine months ended December 31, 2021, compared to the same period of the prior fiscal year, we also experienced supply and demand volatility, as the COVID-19 pandemic and related safety measures and restrictions have evolved differently across the world. In addition, we experienced industry-wide supply chain challenges. The ongoing and full extent of the impact of the COVID-19 pandemic on the Company's business and operational and financial performance and condition, including the sustainability of its effect on trends positive to the Company, is uncertain and will depend on many factors outside the Company's control, including but not limited to the timing, extent, duration and effects of the virus and any of its mutations and variants, the vaccination rates, the development of effective treatments, the imposition of effective public safety and other protective measures and the public's response to such measures, the impact of COVID-19 on the global economy and demand for the Company's products and services. Should the COVID-19 pandemic or global economic slowdown not improve or worsen, or if the Company's attempt to mitigate its impact on its operations and costs is not successful, the Company's business, results of operations, financial condition and prospects may be adversely affected.
v3.21.4
Net Income Per Share (Tables)
9 Months Ended
Dec. 31, 2021
Earnings Per Share [Abstract]  
Schedule of Computations of Basic and Diluted Net Income Per Share
The following table summarizes the computations of basic and diluted net income per share for the three and nine months ended December 31, 2021 and December 31, 2020 (in thousands, except per share amounts):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Net income$210,011 $382,523 $536,308 $721,510 
Shares used in net income per share computation:    
Weighted average shares outstanding - basic167,090 169,050 167,953 168,448 
Effect of potentially dilutive equivalent shares2,617 3,537 3,074 2,930 
Weighted average shares outstanding - diluted169,707 172,587 171,027 171,378 
Net income per share:    
Basic$1.26 $2.26 $3.19 $4.28 
Diluted$1.24 $2.22 $3.14 $4.21 
v3.21.4
Employee Benefit Plans (Tables)
9 Months Ended
Dec. 31, 2021
Share-based Payment Arrangement [Abstract]  
Summary of Share-based Compensation Expenses and Related Tax Benefits Recognized
The following table summarizes the share-based compensation expense and total income tax benefit recognized for share-based awards for the three and nine months ended December 31, 2021 and 2020 (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Cost of goods sold$1,782 $1,747 $5,253 $4,919 
Marketing and selling10,699 8,390 28,987 27,559 
Research and development4,510 3,482 14,295 10,348 
General and administrative7,801 6,195 23,930 21,888 
Total share-based compensation expense24,792 19,814 72,465 64,714 
Income tax benefit(3,581)(3,471)(23,460)(15,540)
Total share-based compensation expense, net of income tax benefit$21,211 $16,343 $49,005 $49,174 
v3.21.4
Balance Sheet Components (Tables)
9 Months Ended
Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]  
Schedule of Components of Certain Balance Sheet Asset Amounts
The following table presents the components of certain balance sheet asset amounts as of December 31 and March 31, 2021 (in thousands): 
December 31, 2021March 31, 2021
Accounts receivable, net:  
Accounts receivable$1,189,206 $867,868 
Allowance for doubtful accounts(75)(1,161)
Allowance for sales returns(15,128)(14,438)
Allowance for cooperative marketing arrangements(66,772)(43,276)
Allowance for customer incentive programs(125,052)(76,200)
Allowance for pricing programs(136,343)(120,568)
 $845,836 $612,225 
Inventories:  
Raw materials$209,647 $146,886 
Finished goods624,887 514,230 
 $834,534 $661,116 
Other current assets:  
Value-added tax receivables$56,944 $67,710 
Prepaid expenses and other assets88,057 67,940 
 $145,001 $135,650 
Property, plant and equipment, net:  
Property, plant and equipment at cost$451,783 $417,520 
Accumulated depreciation and amortization(342,182)(303,460)
$109,601 $114,060 
Other assets:  
Deferred tax assets$196,776 $210,888 
Right-of-use assets 38,997 31,169 
Trading investments for deferred compensation plan29,711 24,809 
Investments in privately held companies43,482 43,402 
Other assets14,639 13,980 
 $323,605 $324,248 
Schedule of Components of Certain Balance Sheet Liability Amounts
The following table presents the components of certain balance sheet liability amounts as of December 31 and March 31, 2021 (in thousands): 
December 31, 2021March 31, 2021
Accrued and other current liabilities:  
Accrued customer marketing, pricing and incentive programs$244,821 $185,394 
Accrued personnel expenses167,249 173,360 
VAT payable41,103 50,620 
Accrued sales return liability37,765 43,178 
Accrued payables - non-inventory29,632 52,392 
Warranty accrual34,121 33,228 
Income taxes payable25,889 131,408 
Operating lease liability13,583 13,101 
Contingent consideration8,580 6,967 
Other current liabilities210,941 168,969 
 $813,684 $858,617 
Other non-current liabilities:  
Employee benefit plan obligations$74,643 $72,321 
Obligation for deferred compensation plan29,711 24,809 
Operating lease liability27,464 21,319 
Warranty accrual13,814 15,604 
Contingent consideration3,971 — 
Deferred tax liability1,679 1,679 
Other non-current liabilities4,087 3,770 
 $155,369 $139,502 
v3.21.4
Fair Value Measurements (Tables)
9 Months Ended
Dec. 31, 2021
Financial Instruments, Owned, at Fair Value [Abstract]  
Schedule of Financial Assets and Liabilities, Classified by Level
The following table presents the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis, excluding assets related to the Company’s defined benefit pension plans, classified by the level within the fair value hierarchy (in thousands): 
 December 31, 2021March 31, 2021
 Level 1Level 2Level 3Level 1Level 2Level 3
Assets:    
Cash equivalents$475,187 $— $— $669,759 $— $— 
       
Trading investments for deferred compensation plan included in other assets:    
Cash$349 $— $— $31 $— $— 
Common stock2,240 — — 1,569 — — 
Money market funds7,117 — — 6,734 — — 
Mutual funds20,005 — — 16,475 — — 
Total of trading investments for deferred compensation plan$29,711 $— $— $24,809 $— $— 
Currency exchange derivative assets
included in other current assets
$— $198 $— $— $5,452 $— 
Liabilities:
Contingent consideration for business acquisition included in accrued and other current liabilities$— $— $8,042 $— $— $6,430 
Contingent consideration for business acquisition included in other non-current liabilities$— $— $3,971 $— $— $— 
Currency exchange derivative liabilities
included in accrued and other current liabilities
$— $808 $— $— $100 $— 
Change in Fair Value of Contingent Consideration
The following table summarizes the change in the fair value of the Company's contingent consideration balance during the nine months ended December 31, 2021 and 2020 (in thousands):
Nine Months Ended
December 31,
20212020
Beginning of the period$6,967 $23,284 
Fair value of contingent consideration upon acquisition (1)
9,973 — 
Change in fair value of contingent consideration(3,509)5,716 
Settlement of contingent consideration(880)(28,463)
End of the period (2)
$12,551 $537 
(1) Fair value of contingent consideration includes the earn-out of the immaterial technology acquisition. See Contingent Consideration for Business Acquisitions section below for more information.
(2) As of June 30, 2020, the earn-out period was completed in connection with our acquisition of General Workings, Inc. ("Streamlabs") (discussed below). The earn-out payment of $29.0 million was based on the actual net sales of Streamlabs services during the earn-out period and was no longer subject to fair value measurement and was accordingly transferred out of Level 3. During the third quarter of fiscal year 2021, $28.5 million of the contingent consideration was transferred from other current liabilities to equity upon settlement of the contingent consideration through the issuance of shares out of treasury stock. The remaining $0.5 million is held back in escrow for claims made against the escrow and for the payment of taxes.
v3.21.4
Derivative Financial Instruments (Tables)
9 Months Ended
Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of Gains and Losses on Derivative Instruments The following table presents the amounts of gains (losses) on the Company’s derivative instruments designated as hedging instruments and their locations on its condensed consolidated statements of operations and condensed consolidated statements of comprehensive income for the three and nine months ended December 31, 2021 and 2020 (in thousands):
Three Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss
Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
 2021202020212020
Cash flow hedges$1,061 $(6,326)$(3,200)$3,446 
Nine Months Ended
December 31,
Amount of Gain (Loss)
Deferred as a Component of Accumulated
Other Comprehensive Loss
Amount of Loss (Gain)
Reclassified from Accumulated Other Comprehensive Loss to
Costs of Goods Sold
2021202020212020
Cash flow hedges$3,723 $(9,752)$(5,108)$5,085 
v3.21.4
Goodwill and Other Intangible Assets (Tables)
9 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
Summary of Activity In Goodwill Balance
The following table summarizes the activities in the Company’s goodwill balance during the nine months ended December 31, 2021 (in thousands):

As of March 31, 2021$429,604 
Acquisition20,721 
Effects of foreign currency translation(1,594)
As of December 31, 2021$448,731 
Schedule of Intangible Assets Subject to Amortization
The Company's acquired intangible assets subject to amortization were as follows (in thousands):
 December 31, 2021March 31, 2021
 Gross Carrying AmountAccumulated
Amortization
Net Carrying AmountGross Carrying AmountAccumulated
Amortization
Net Carrying Amount
Trademark and trade names$36,790 $(21,112)$15,678 $46,070 $(25,153)$20,917 
Developed technology119,707 (80,545)39,162 134,406 (90,450)43,956 
Customer contracts/relationships71,110 (39,172)31,938 91,010 (44,261)46,749 
In-process R&D3,526 — 3,526 3,526 — 3,526 
Effects of foreign currency translation(475)49 (426)— — — 
Total$230,658 $(140,780)$89,878 $275,012 $(159,864)$115,148 
v3.21.4
Commitments and Contingencies (Tables)
9 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Changes in Warranty Liability
Changes in the Company’s warranty liability for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands): 
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Beginning of the period$49,173 $41,782 $48,832 $40,039 
Provision6,962 13,692 23,503 28,575 
Settlements(8,056)(8,371)(24,219)(22,073)
Effects of foreign currency translation(144)489 (181)1,051 
End of the period$47,935 $47,592 $47,935 $47,592 
v3.21.4
Shareholders' Equity (Tables)
9 Months Ended
Dec. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of Components of Accumulated Other Comprehensive Income (Loss)
The accumulated other comprehensive income (loss) was as follows (in thousands):
 Accumulated Other Comprehensive Income (Loss)
Cumulative
Translation
Adjustment
Defined
Benefit
Plan
Deferred Hedging Gains / (Losses)Total
March 31, 2021$(89,461)$(23,200)$3,746 $(108,915)
Other comprehensive gains (losses)(8,682)(214)(1,385)(10,281)
December 31, 2021$(98,143)$(23,414)$2,361 $(119,196)
v3.21.4
Segment Information (Tables)
9 Months Ended
Dec. 31, 2021
Segment Reporting [Abstract]  
Schedule of Net Sales by Product Categories, Excluding Intercompany Transactions
Sales by product categories and sales channels, excluding intercompany transactions, for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
 2021202020212020
Pointing Devices$231,090 $213,638 $602,982 $503,228 
Keyboards & Combos281,608 218,269 736,237 565,246 
PC Webcams115,115 131,700 319,504 295,020 
Tablet & Other Accessories82,859 138,052 242,932 267,186 
Gaming (1)
469,282 436,426 1,135,456 916,040 
Video Collaboration287,187 292,500 753,725 659,278 
Mobile Speakers56,748 72,566 124,724 145,156 
Audio & Wearables104,280 152,952 318,965 338,592 
Smart Home4,559 10,593 16,380 25,976 
Other (2)
54 606 202 632 
Total Sales$1,632,782 $1,667,302 $4,251,107 $3,716,354 

(1) Gaming includes streaming services revenue generated by Streamlabs.
(2) Other includes products that the Company currently intends to phase out, or has already phased out, because they are no longer strategic to the Company's business.
Schedule of Net Sales by Geographic Region
Sales by geographic region (based on the customers’ locations) for the three and nine months ended December 31, 2021 and 2020 were as follows (in thousands):
Three Months Ended
December 31,
Nine Months Ended
December 31,
2021202020212020
Americas$674,393 $704,718 $1,828,474 $1,603,221 
EMEA552,133 547,044 1,309,542 1,147,393 
Asia Pacific406,256 415,540 1,113,091 965,740 
Total sales$1,632,782 $1,667,302 $4,251,107 $3,716,354 
Schedule of Long-Lived Assets by Geographic Region
Property, plant and equipment, net by geographic region were as follows (in thousands):
December 31, 2021March 31, 2021
Americas$18,071 $20,810 
EMEA15,245 8,019 
Asia Pacific76,285 85,231 
Total property, plant and equipment, net$109,601 $114,060 
v3.21.4
Restructuring (Tables)
9 Months Ended
Dec. 31, 2021
Restructuring and Related Activities [Abstract]  
Schedule of Rollforward of Restructuring Activities
The following table presents a rollforward of the restructuring liability for the nine months ended December 31, 2021 (in thousands):
 Termination
Benefits
OtherTotal
Accrual balance at March 31, 2021$— $— $— 
Charges472 1,287 1,759 
Cash payments— — — 
Accrual balance at December 31, 2021$472 $1,287 $1,759 
v3.21.4
Net Income Per Share - Computations of Basic and Diluted Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Earnings Per Share [Abstract]        
Net income $ 210,011 $ 382,523 $ 536,308 $ 721,510
Shares used in net income per share computation:        
Weighted average shares outstanding - basic (in shares) 167,090 169,050 167,953 168,448
Effect of potentially dilutive equivalent shares (in shares) 2,617 3,537 3,074 2,930
Weighted average shares outstanding - diluted (in shares) 169,707 172,587 171,027 171,378
Net income per share:        
Basic (in dollars per share) $ 1.26 $ 2.26 $ 3.19 $ 4.28
Diluted (in dollars per share) $ 1.24 $ 2.22 $ 3.14 $ 4.21
Anti-dilutive equivalents shares excluded (in shares) 800 300 900 400
v3.21.4
Employee Benefit Plans - Share-based Compensation Expenses and Related Tax Benefits Recognized (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Share-based compensation expense and related tax benefit        
Total share-based compensation expense $ 24,792 $ 19,814 $ 72,465 $ 64,714
Income tax benefit (3,581) (3,471) (23,460) (15,540)
Total share-based compensation expense, net of income tax benefit 21,211 16,343 49,005 49,174
Cost of goods sold        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 1,782 1,747 5,253 4,919
Marketing and selling        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 10,699 8,390 28,987 27,559
Research and development        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense 4,510 3,482 14,295 10,348
General and administrative        
Share-based compensation expense and related tax benefit        
Total share-based compensation expense $ 7,801 $ 6,195 $ 23,930 $ 21,888
v3.21.4
Employee Benefit Plans - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Share-based Compensation        
Share-based compensation expenses capitalized as inventory     $ 1.1 $ 1.0
Defined benefit plans        
Net periodic benefit cost $ 3.4 $ 2.9 $ 10.0 $ 8.3
v3.21.4
Income Taxes (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Operating Loss Carryforwards [Line Items]          
Provision for income taxes $ 49,345 $ 72,334 $ 107,789 $ 142,638  
Effective income tax rates (as a percent) 19.00% 15.90% 16.70% 16.50%  
Discrete tax benefits from recognition of excess tax benefits $ 800 $ 1,300 $ 15,200 $ 7,200  
Reversal of uncertain tax positions 1,300 $ 1,400 2,800 $ 2,900  
Unrecognized tax benefits 178,600   178,600   $ 160,300
Accrued interest and penalties related to uncertain tax positions 5,700   5,700   4,900
Expected decrease in uncertain tax positions 5,200   5,200    
Non-current income tax payable          
Operating Loss Carryforwards [Line Items]          
Unrecognized tax benefits $ 85,600   $ 85,600   $ 59,200
v3.21.4
Balance Sheet Components - Components of Certain Balance Sheet Asset Amounts (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Accounts receivable, net:    
Accounts receivable $ 1,189,206 $ 867,868
Accounts receivable, net 845,836 612,225
Inventories:    
Raw materials 209,647 146,886
Finished goods 624,887 514,230
Inventory, net 834,534 661,116
Other current assets:    
Value-added tax receivables 56,944 67,710
Prepaid expenses and other assets 88,057 67,940
Other current assets, total 145,001 135,650
Property, plant and equipment, net:    
Property, plant and equipment at cost 451,783 417,520
Accumulated depreciation and amortization (342,182) (303,460)
Property, plant and equipment, net 109,601 114,060
Other assets:    
Deferred tax assets 196,776 210,888
Right-of-use assets 38,997 31,169
Trading investments for deferred compensation plan 29,711 24,809
Investments in privately held companies 43,482 43,402
Other assets 14,639 13,980
Other assets, total $ 323,605 324,248
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Other assets, total  
Allowance for doubtful accounts    
Accounts receivable, net:    
Valuation allowance for accounts receivable $ (75) (1,161)
Allowance for sales returns    
Accounts receivable, net:    
Valuation allowance for accounts receivable (15,128) (14,438)
Allowance for cooperative marketing arrangements    
Accounts receivable, net:    
Valuation allowance for accounts receivable (66,772) (43,276)
Allowance for customer incentive programs    
Accounts receivable, net:    
Valuation allowance for accounts receivable (125,052) (76,200)
Allowance for pricing programs    
Accounts receivable, net:    
Valuation allowance for accounts receivable $ (136,343) $ (120,568)
v3.21.4
Balance Sheet Components - Components of Certain Balance Sheet Liability Amounts (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Accrued and other current liabilities:    
Accrued customer marketing, pricing and incentive programs $ 244,821 $ 185,394
Accrued personnel expenses 167,249 173,360
VAT payable 41,103 50,620
Accrued sales return liability 37,765 43,178
Accrued payables - non-inventory 29,632 52,392
Warranty accrual 34,121 33,228
Income taxes payable 25,889 131,408
Operating lease liability 13,583 13,101
Contingent consideration 8,580 6,967
Other current liabilities 210,941 168,969
Accrued and other current liabilities $ 813,684 858,617
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Accrued and other current liabilities  
Other non-current liabilities:    
Employee benefit plan obligations $ 74,643 72,321
Obligation for deferred compensation plan 29,711 24,809
Operating lease liability 27,464 21,319
Warranty accrual 13,814 15,604
Contingent consideration 3,971 0
Deferred tax liability 1,679 1,679
Other non-current liabilities 4,087 3,770
Non-current liabilities $ 155,369 $ 139,502
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Non-current liabilities  
v3.21.4
Fair Value Measurements - Financial Assets and Liabilities, Classified by Level (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Assets:    
Trading investments for deferred compensation plan $ 29,711 $ 24,809
Liabilities:    
Contingent consideration for business acquisition included in accrued and other current liabilities 8,580 6,967
Contingent consideration for business acquisition included in other non-current liabilities 3,971 0
Fair Value, Measurements, Recurring | Level 1    
Assets:    
Cash equivalents 475,187 669,759
Trading investments for deferred compensation plan 29,711 24,809
Currency exchange derivative assets included in other current assets 0 0
Liabilities:    
Contingent consideration for business acquisition included in accrued and other current liabilities 0 0
Contingent consideration for business acquisition included in other non-current liabilities 0 0
Currency exchange derivative liabilities included in accrued and other current liabilities 0 0
Fair Value, Measurements, Recurring | Level 1 | Cash    
Assets:    
Trading investments for deferred compensation plan 349 31
Fair Value, Measurements, Recurring | Level 1 | Common stock    
Assets:    
Trading investments for deferred compensation plan 2,240 1,569
Fair Value, Measurements, Recurring | Level 1 | Money market funds    
Assets:    
Trading investments for deferred compensation plan 7,117 6,734
Fair Value, Measurements, Recurring | Level 1 | Mutual funds    
Assets:    
Trading investments for deferred compensation plan 20,005 16,475
Fair Value, Measurements, Recurring | Level 2    
Assets:    
Cash equivalents 0 0
Trading investments for deferred compensation plan 0 0
Currency exchange derivative assets included in other current assets 198 5,452
Liabilities:    
Contingent consideration for business acquisition included in accrued and other current liabilities 0 0
Contingent consideration for business acquisition included in other non-current liabilities 0 0
Currency exchange derivative liabilities included in accrued and other current liabilities 808 100
Fair Value, Measurements, Recurring | Level 2 | Cash    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 2 | Common stock    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 2 | Money market funds    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 2 | Mutual funds    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 3    
Assets:    
Cash equivalents 0 0
Trading investments for deferred compensation plan 0 0
Currency exchange derivative assets included in other current assets 0 0
Liabilities:    
Contingent consideration for business acquisition included in accrued and other current liabilities 8,042 6,430
Contingent consideration for business acquisition included in other non-current liabilities 3,971 0
Currency exchange derivative liabilities included in accrued and other current liabilities 0 0
Fair Value, Measurements, Recurring | Level 3 | Cash    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 3 | Common stock    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 3 | Money market funds    
Assets:    
Trading investments for deferred compensation plan 0 0
Fair Value, Measurements, Recurring | Level 3 | Mutual funds    
Assets:    
Trading investments for deferred compensation plan $ 0 $ 0
v3.21.4
Fair Value Measurements - Change in Fair Value of Contingent Consideration (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2020
Oct. 31, 2019
Dec. 31, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Change in Fair Value of Contingent Consideration [Roll Forward]            
Beginning of the period       $ 23,284 $ 6,967 $ 23,284
Fair value of contingent consideration upon acquisition         9,973 0
Change in fair value of contingent consideration         (3,509) 5,716
Settlement of contingent consideration     $ (28,500)   (880) (28,463)
End of the period     537   $ 12,551 $ 537
Amounts held in escrow     500      
Streamlabs            
Change in Fair Value of Contingent Consideration [Roll Forward]            
Change in fair value of contingent consideration       $ 5,700    
Settlement of contingent consideration     (28,500)      
Future potential earn-out payments $ 29,000 $ 29,000        
Amounts held in escrow     $ 500      
v3.21.4
Fair Value Measurements - Narrative (Details)
3 Months Ended 9 Months Ended
May 19, 2021
USD ($)
milestone
Feb. 17, 2021
USD ($)
Jan. 04, 2021
USD ($)
milestone
Jun. 30, 2020
USD ($)
Oct. 31, 2019
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Jun. 30, 2020
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Mar. 31, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Trading investments for deferred compensation plan           $ 29,711,000     $ 29,711,000   $ 24,809,000
Payment of contingent consideration for business acquisition           900,000     880,000 $ 0  
Change in fair value of contingent consideration                 (3,509,000) 5,716,000  
Contingent consideration transferred to equity classification             $ 28,500,000   880,000 28,463,000  
Amounts held in escrow             500,000        
Equity method investments           40,800,000     40,800,000   40,700,000
Impairment of non-marketable investments           0 0   0 0  
Impairment of long-lived assets held-for-use           0 0   0 0  
Impairment of intangible assets           7,000,000 0   7,000,000 0  
Impairment of non-financial assets           0 0   0 $ 0  
Fair Value, Measurements, Recurring | Level 1                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Trading investments for deferred compensation plan           $ 29,711,000     $ 29,711,000   24,809,000
Small Technology Acquisition                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Future potential earn-out payments $ 10,000,000   $ 3,000,000                
Number of technical development milestones | milestone 3   2                
Mevo                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Future potential earn-out payments   $ 17,000,000                  
Contingent consideration   $ 3,400,000                 $ 3,400,000
Streamlabs                      
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                      
Future potential earn-out payments       $ 29,000,000 $ 29,000,000            
Change in fair value of contingent consideration               $ 5,700,000      
Contingent consideration transferred to equity classification             28,500,000        
Amounts held in escrow             $ 500,000        
v3.21.4
Derivative Financial Instruments - Gains and Losses on Derivative Instruments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Amounts of gains and losses on the derivative instruments        
Amount of Gain (Loss) Deferred as a Component of Accumulated Other Comprehensive Loss $ 1,061 $ (6,326) $ 3,723 $ (9,752)
Amount of Loss (Gain) Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold (3,200) 3,446 (5,108) 5,085
Designated as hedging instruments | Cash flow hedges        
Amounts of gains and losses on the derivative instruments        
Amount of Gain (Loss) Deferred as a Component of Accumulated Other Comprehensive Loss 1,061 (6,326) 3,723 (9,752)
Amount of Loss (Gain) Reclassified from Accumulated Other Comprehensive Loss to Costs of Goods Sold $ (3,200) $ 3,446 $ (5,108) $ 5,085
v3.21.4
Derivative Financial Instruments - Narrative (Details) - USD ($)
$ in Millions
9 Months Ended
Dec. 31, 2021
Mar. 31, 2021
Derivative [Line Items]    
Additional term to recognize derivative loss in Accumulated Other Comprehensive Loss 2 months  
Not Designated as Hedging Instrument | Foreign Exchange Forward And Swap    
Derivative [Line Items]    
Derivative term of contract 1 month  
Derivative, notional amount $ 251.7 $ 123.8
Foreign Exchange Forward | Designated as hedging instruments | Cash flow hedges    
Derivative [Line Items]    
Derivative term of contract 4 months  
Derivative, notional amount $ 128.1 $ 164.5
Cash flow hedge gains to be reclassified within twelve months $ 2.4  
v3.21.4
Goodwill and Other Intangible Assets - Summary of Activity In Goodwill Balance (Details)
$ in Thousands
3 Months Ended 9 Months Ended
May 19, 2021
USD ($)
milestone
Jan. 04, 2021
USD ($)
milestone
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Goodwill            
Balance at the beginning of the period         $ 429,604  
Acquisition         20,721  
Effects of foreign currency translation         (1,594)  
Balance at the end of the period     $ 448,731   448,731  
Impairment of intangible assets     $ 7,000 $ 0 $ 7,000 $ 0
Small Technology Acquisition            
Goodwill            
Payments to acquire business, gross $ 25,600          
Future potential earn-out payments $ 10,000 $ 3,000        
Number of technical development milestones | milestone 3 2        
Total consideration retained (as a percent) 6.00%          
v3.21.4
Goodwill and Other Intangible Assets - Schedule of Intangible Assets Subject to Amortization (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 230,658 $ 275,012
Accumulated Amortization (140,780) (159,864)
Net Carrying Amount 89,878 115,148
Effects of foreign currency translation, Gross Carrying Amount (475) 0
Effects of foreign currency translation, Accumulated Amortization 49 0
Effects of foreign currency translation, Net Carrying Amount (426) 0
In-process R&D    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 3,526 3,526
Net Carrying Amount 3,526 3,526
Trademark and trade names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 36,790 46,070
Accumulated Amortization (21,112) (25,153)
Net Carrying Amount 15,678 20,917
Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 119,707 134,406
Accumulated Amortization (80,545) (90,450)
Net Carrying Amount 39,162 43,956
Customer contracts/relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 71,110 91,010
Accumulated Amortization (39,172) (44,261)
Net Carrying Amount $ 31,938 $ 46,749
v3.21.4
Financing Arrangements (Details) - USD ($)
Dec. 31, 2021
Mar. 31, 2021
Financing Arrangements    
Outstanding borrowings $ 0 $ 0
Line of Credit    
Financing Arrangements    
Maximum borrowing capacity 194,400,000  
Outstanding bank guarantees $ 11,800,000  
v3.21.4
Commitments and Contingencies - Changes in Warranty Liability (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Changes in the warranty liability:        
Beginning of the period $ 49,173 $ 41,782 $ 48,832 $ 40,039
Provision 6,962 13,692 23,503 28,575
Settlements (8,056) (8,371) (24,219) (22,073)
Effects of foreign currency translation (144) 489 (181) 1,051
End of the period $ 47,935 $ 47,592 $ 47,935 $ 47,592
v3.21.4
Commitments and Contingencies - Narrative (Details)
Dec. 31, 2021
USD ($)
Indemnification agreement  
Other Commitments [Line Items]  
Amount accrued for indemnification provisions $ 0
v3.21.4
Shareholders' Equity - Narrative (Details)
1 Months Ended 3 Months Ended 9 Months Ended
Apr. 30, 2021
USD ($)
May 31, 2020
USD ($)
shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
SFr / shares
Dec. 31, 2020
USD ($)
$ / shares
Dec. 31, 2020
SFr / shares
Mar. 31, 2017
USD ($)
shares
Class of Stock [Line Items]                
Cash dividends per share (in dollars per share) | (per share)     $ 0.95 $ 0.95 SFr 0.87 $ 0.87 SFr 0.79  
Payment of cash dividends       $ 159,410,000   $ 146,705,000    
March 2017                
Class of Stock [Line Items]                
Authorized amount in buyback program               $ 250,000,000
Shares authorized to be repurchased (in shares) | shares               17,300,000
May 2020                
Class of Stock [Line Items]                
Authorized amount in buyback program   $ 250,000,000            
Shares authorized to be repurchased (in shares) | shares   17,300,000            
Period to complete share repurchase program   3 years            
Increase in authorized amount $ 750,000,000              
Amount available for repurchase     $ 545,000,000.0 $ 545,000,000.0 SFr 545,000,000.0      
April 2021                
Class of Stock [Line Items]                
Authorized amount in buyback program $ 1,000,000,000              
v3.21.4
Shareholders' Equity - Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period $ 2,262,683 $ 1,705,963 $ 2,261,789 $ 1,489,268
Other comprehensive gains (losses) (8,177) 15,935 (10,281) 17,743
End of the period 2,367,942 2,101,767 2,367,942 2,101,767
Total        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period (111,019) (118,852) (108,915) (120,660)
End of the period (119,196) $ (102,917) (119,196) $ (102,917)
Cumulative Translation Adjustment        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     (89,461)  
Other comprehensive gains (losses)     (8,682)  
End of the period (98,143)   (98,143)  
Defined Benefit Plan        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     (23,200)  
Other comprehensive gains (losses)     (214)  
End of the period (23,414)   (23,414)  
Deferred Hedging Gains / (Losses)        
Accumulated Other Comprehensive Income (Loss)        
Beginning of the period     3,746  
Other comprehensive gains (losses)     (1,385)  
End of the period $ 2,361   $ 2,361  
v3.21.4
Segment Information - Net Sales by Product Categories, Excluding Intercompany Transactions (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Segment Reporting Information [Line Items]        
Net sales $ 1,632,782 $ 1,667,302 $ 4,251,107 $ 3,716,354
Pointing Devices        
Segment Reporting Information [Line Items]        
Net sales 231,090 213,638 602,982 503,228
Keyboards & Combos        
Segment Reporting Information [Line Items]        
Net sales 281,608 218,269 736,237 565,246
PC Webcams        
Segment Reporting Information [Line Items]        
Net sales 115,115 131,700 319,504 295,020
Tablet & Other Accessories        
Segment Reporting Information [Line Items]        
Net sales 82,859 138,052 242,932 267,186
Gaming        
Segment Reporting Information [Line Items]        
Net sales 469,282 436,426 1,135,456 916,040
Video Collaboration        
Segment Reporting Information [Line Items]        
Net sales 287,187 292,500 753,725 659,278
Mobile Speakers        
Segment Reporting Information [Line Items]        
Net sales 56,748 72,566 124,724 145,156
Audio & Wearables        
Segment Reporting Information [Line Items]        
Net sales 104,280 152,952 318,965 338,592
Smart Home        
Segment Reporting Information [Line Items]        
Net sales 4,559 10,593 16,380 25,976
Other        
Segment Reporting Information [Line Items]        
Net sales $ 54 $ 606 $ 202 $ 632
v3.21.4
Segment Information - Net Sales and Long-Lived Assets by Geographic Region (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Mar. 31, 2021
Net sales to unaffiliated customers and long-lived assets by geographic region          
Net sales $ 1,632,782 $ 1,667,302 $ 4,251,107 $ 3,716,354  
Property, plant and equipment, net 109,601   109,601   $ 114,060
Americas          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Net sales 674,393 704,718 1,828,474 1,603,221  
Property, plant and equipment, net 18,071   18,071   20,810
EMEA          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Net sales 552,133 547,044 1,309,542 1,147,393  
Property, plant and equipment, net 15,245   15,245   8,019
Asia Pacific          
Net sales to unaffiliated customers and long-lived assets by geographic region          
Net sales 406,256 $ 415,540 1,113,091 $ 965,740  
Property, plant and equipment, net $ 76,285   $ 76,285   $ 85,231
v3.21.4
Segment Information - Narrative (Details)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
USD ($)
Dec. 31, 2020
Dec. 31, 2021
USD ($)
segment
Dec. 31, 2020
Mar. 31, 2021
USD ($)
Segment Reporting Information [Line Items]          
Number of operating segments | segment     1    
Long lived assets $ 109,601   $ 109,601   $ 114,060
Switzerland          
Segment Reporting Information [Line Items]          
Long lived assets 12,700   12,700   5,700
United States          
Segment Reporting Information [Line Items]          
Long lived assets 17,800   17,800   20,500
China          
Segment Reporting Information [Line Items]          
Long lived assets $ 64,100   $ 64,100   $ 74,000
Geographic Concentration | Consolidated net sales from continuing operations | Switzerland          
Segment Reporting Information [Line Items]          
Percentage of consolidated net sales 3.00% 3.00% 3.00% 3.00%  
v3.21.4
Restructuring - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credits), net $ 1,759 $ 0 $ 1,770 $ (54)
Impairment of intangible assets 7,000 $ 0 7,000 $ 0
Discontinued Operations        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credits), net 1,800   1,759  
Total restructuring charges 16,300   16,300  
Inventory write-offs in cost of goods sold 7,600   7,600  
Impairment of intangible assets 7,000   7,000  
Purchase Order Cancellation Fees | Discontinued Operations        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credits), net 1,300   1,300  
Termination Benefits | Discontinued Operations        
Restructuring Cost and Reserve [Line Items]        
Restructuring charges (credits), net $ 500   $ 472  
v3.21.4
Restructuring - Schedule of Rollforward of Restructuring Activities (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Restructuring Reserve [Roll Forward]        
Charges $ 1,759 $ 0 $ 1,770 $ (54)
Discontinued Operations        
Restructuring Reserve [Roll Forward]        
Beginning balance     0  
Charges 1,800   1,759  
Cash payments     0  
Ending balance 1,759   1,759  
Termination Benefits | Discontinued Operations        
Restructuring Reserve [Roll Forward]        
Beginning balance     0  
Charges 500   472  
Cash payments     0  
Ending balance 472   472  
Other | Discontinued Operations        
Restructuring Reserve [Roll Forward]        
Beginning balance     0  
Charges     1,287  
Cash payments     0  
Ending balance $ 1,287   $ 1,287